AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35274420 — intervention group
Group type: EXPERIMENTAL
Intervention: KCCQ-PLS deterioration
Number of subjects: 698
Study 35274420 — intervention group
Group type: EXPERIMENTAL
Intervention: KCCQ-PLS meaningful change
Number of subjects: 698
Study 35274420 — intervention group
Group type: EXPERIMENTAL
Intervention: KCCQ-PLS AUC analysis
Number of subjects: 698
Study 35274420 — intervention group
Group type: EXPERIMENTAL
Intervention: KCCQ-PLS minimal clinically important difference
Number of subjects: 698
Study 32740778 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic Assessment Clinic
Number of subjects: 0
Study 32740778 — intervention group
Group type: COMPARATOR
Intervention: Standard assessment
Number of subjects: 0
Study 32090699 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylloquinone (vitamin K1) supplementation
Number of subjects: 48
Study 32090699 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline plasma phylloquinone concentrations
Number of subjects: 48
Study 33586819 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy programme without additional videoconference sessions
Number of subjects: 77
Study 33586819 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy programme with additional videoconference sessions
Number of subjects: 77
Study 33586819 — intervention group
Group type: COMPARATOR
Intervention: Both groups (iCBT with and without videoconference guidance)
Number of subjects: 77
Study 34786956 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg every 8 weeks
Number of subjects: 0
Study 34786956 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 10 mg every 8 weeks
Number of subjects: 0
Study 34786956 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg/day
Number of subjects: 0
Study 34305792 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback prior to robot-assisted training
Number of subjects: 40
Study 34305792 — intervention group
Group type: COMPARATOR
Intervention: Sham-mirror visual feedback prior to robot-assisted training
Number of subjects: 40
Study 35416456 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical total disc replacement (CTDR)
Number of subjects: 72
Study 35416456 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 72
Study 36153623 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Tai Chi Chuan (MBTCC)
Number of subjects: 256
Study 36153623 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 256
Study 36153623 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC)
Number of subjects: 256
Study 36153623 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene education (SHE)
Number of subjects: 256
Study 34052118 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help relaxation exercise twice per day for 4 weeks
Number of subjects: 30
Study 32912351 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery-enhanced CBT (IE-CBT)
Number of subjects: 107
Study 32912351 — intervention group
Group type: COMPARATOR
Intervention: Verbally-based CBT (VB-CBT)
Number of subjects: 107
Study 33604488 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional marine diet (high fat, low carbohydrate)
Number of subjects: 60
Study 33604488 — intervention group
Group type: COMPARATOR
Intervention: Western diet
Number of subjects: 60
Study 33484279 — intervention group
Group type: EXPERIMENTAL
Intervention: Burosumab
Number of subjects: 35
Study 33484279 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 35
Study 32966714 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg or 15 mg)
Number of subjects: 8246
Study 32966714 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg)
Number of subjects: 8246
Study 32966714 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (15 mg)
Number of subjects: 8246
Study 32966714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8246
Study 35858870 — intervention group
Group type: EXPERIMENTAL
Intervention: PrAISED intervention (individually tailored physical exercises and functional activities delivered via phone or video calling)
Number of subjects: 30
Study 33599809 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4-g/kg dose of alcohol
Number of subjects: 31
Study 33599809 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 31
Study 34259441 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemplative mental training (3 or 9 months)
Number of subjects: 332
Study 34338104 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness practice group
Number of subjects: 50
Study 34338104 — intervention group
Group type: COMPARATOR
Intervention: Active control group (listening to stories)
Number of subjects: 50
Study 33245582 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ cell count >32 × 10^6/L
Number of subjects: 68
Study 33245582 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ cell yield of the first apheresis >2.75 × 10^6/kg
Number of subjects: 68
Study 33245582 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ cell count >2.65 × 10^6/kg
Number of subjects: 68
Study 33245582 — intervention group
Group type: EXPERIMENTAL
Intervention: graft CD34+CD133+CD38− cell count >0.07 × 10^6/kg
Number of subjects: 68
Study 33245582 — intervention group
Group type: EXPERIMENTAL
Intervention: graft CD3+ cell count >23.1 × 10^6/kg
Number of subjects: 68
Study 33245582 — intervention group
Group type: EXPERIMENTAL
Intervention: disease status of CR I at auto-SCT
Number of subjects: 68
Study 35449191 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 0
Study 35449191 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 0
Study 34366890 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) for 20 min once weekly (n = 27)
Number of subjects: 54
Study 34366890 — intervention group
Group type: COMPARATOR
Intervention: Non-WB-EMS control group (CG, n = 27)
Number of subjects: 54
Study 35544171 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment group
Number of subjects: 0
Study 35544171 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study 33933665 — intervention group
Group type: EXPERIMENTAL
Intervention: ML digital support platform (PRESTO) with a smartphone app for monitoring and delivering psychological interventions for anxiety and depressive symptoms.
Number of subjects: 0
Study 33933665 — intervention group
Group type: EXPERIMENTAL
Intervention: ML predictive severity model based on cases referred to the PC mental health support programme.
Number of subjects: 0
Study 33243032 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration combined with reduced glutathione
Number of subjects: 396
Study 33243032 — intervention group
Group type: COMPARATOR
Intervention: Hydration alone (control)
Number of subjects: 396
Study 34501908 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive comment
Number of subjects: 211
Study 34501908 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative comment
Number of subjects: 211
Study 34501908 — intervention group
Group type: COMPARATOR
Intervention: No comment
Number of subjects: 211
Study 33243812 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted pulmonary rehabilitation (PR) program consisting of 12 sessions of exercise and health education over 6 weeks
Number of subjects: 50
Study 33243812 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 50
Study 35381686 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily for 14 days)
Number of subjects: 116
Study 35381686 — intervention group
Group type: COMPARATOR
Intervention: Cilostazol (200 mg daily for 14 days)
Number of subjects: 116
Study 34227198 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/day milled flaxseed
Number of subjects: 60
Study 34227198 — intervention group
Group type: COMPARATOR
Intervention: 30 g/day milled rice
Number of subjects: 60
Study 32873289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with instrumented gait analysis
Number of subjects: 60
Study 32873289 — intervention group
Group type: COMPARATOR
Intervention: Care as usual without instrumented gait analysis
Number of subjects: 60
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Open panoramic scanner
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright open scanner
Number of subjects: 160
Study 32876831 — intervention group
Group type: COMPARATOR
Intervention: Short-bore scanner
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-bore scanner with better diagnostic performance information
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with claustrophobic events
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients scanned in a short-bore scanner
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise reduction
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: More space over the head
Number of subjects: 160
Study 32876831 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall more space
Number of subjects: 160
Study 32436794 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mL of a 2% lidocaine–0.5% bupivacaine mixture
Number of subjects: 6
Study 32436794 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL of a 2% lidocaine–0.5% bupivacaine mixture
Number of subjects: 6
Study 32436794 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL of a 2% lidocaine–0.5% bupivacaine mixture
Number of subjects: 6
Study 32436794 — intervention group
Group type: COMPARATOR
Intervention: Contralateral MC (control)
Number of subjects: 6
Study 35259025 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrafamilial cases (stranger and babysitter)
Number of subjects: 292
Study 35259025 — intervention group
Group type: EXPERIMENTAL
Intervention: Stranger
Number of subjects: 292
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: High quality video
Number of subjects: 93
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium quality video
Number of subjects: 93
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: Low quality video
Number of subjects: 93
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: Errors presented in video sequences
Number of subjects: 93
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased compression depth error
Number of subjects: 93
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: Alleged errors not shown in video sequences
Number of subjects: 93
Study 34418968 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional differences
Number of subjects: 93
Study 32338190 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative splinting
Number of subjects: 28
Study 32338190 — intervention group
Group type: COMPARATOR
Intervention: Extension-block pinning
Number of subjects: 28
Study 36215059 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy scoliosis-specific exercise (PSSE) - 'Schroth' exercises for 8 weeks (16 sessions)
Number of subjects: 29
Study 36215059 — intervention group
Group type: COMPARATOR
Intervention: Control group - waiting list
Number of subjects: 29
Study 34006053 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu AuraGain (AA) group
Number of subjects: 66
Study 34006053 — intervention group
Group type: COMPARATOR
Intervention: Air-Q (AQ) group
Number of subjects: 66
Study 32667635 — intervention group
Group type: EXPERIMENTAL
Intervention: No Nasogastric Tube Decompression (NGTD)
Number of subjects: 111
Study 32667635 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric Tube Decompression (NGTD)
Number of subjects: 111
Study 35293364 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Lifestyle Balance (GLB‐TBI) intervention with mHealth app
Number of subjects: 56
Study 35293364 — intervention group
Group type: COMPARATOR
Intervention: Brain Health Group (BHG‐TBI) active control intervention with mHealth app
Number of subjects: 56
Study 34977071 — intervention group
Group type: EXPERIMENTAL
Intervention: VST (VivaSight‐SL)
Number of subjects: 48
Study 34977071 — intervention group
Group type: COMPARATOR
Intervention: VL (Videolaryngoscopy)
Number of subjects: 48
Study 34942227 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DMPFC-rTMS
Number of subjects: 20
Study 34942227 — intervention group
Group type: COMPARATOR
Intervention: Sham DMPFC-rTMS
Number of subjects: 20
Study 32654802 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab
Number of subjects: 142
Study 32654802 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 142
Study 34865664 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (USG)
Number of subjects: 270
Study 34865664 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard technique
Number of subjects: 270
Study 34865664 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-Infrared Light (NIR)
Number of subjects: 270
Study 32282472 — intervention group
Group type: EXPERIMENTAL
Intervention: EE‐DCR with LOS intubation (Group A)
Number of subjects: 0
Study 32282472 — intervention group
Group type: COMPARATOR
Intervention: EE‐DCR without LOS intubation (Group B)
Number of subjects: 0
Study 35562681 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge followed by geriatric interdisciplinary home rehabilitation
Number of subjects: 20
Study 35562681 — intervention group
Group type: COMPARATOR
Intervention: In-hospital care according to a multifactorial rehabilitation program
Number of subjects: 20
Study 34260795 — intervention group
Group type: EXPERIMENTAL
Intervention: Apararenone 10 mg/day
Number of subjects: 48
Study 34260795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32539752 — intervention group
Group type: EXPERIMENTAL
Intervention: Open fenestration discectomy (Group A)
Number of subjects: 60
Study 32539752 — intervention group
Group type: COMPARATOR
Intervention: Fenestration microdiscectomy (Group B)
Number of subjects: 60
Study 36483140 — intervention group
Group type: EXPERIMENTAL
Intervention: Workbook plus a single MI session (WMI)
Number of subjects: 186
Study 36483140 — intervention group
Group type: EXPERIMENTAL
Intervention: Workbook (WB)
Number of subjects: 186
Study 36483140 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control (DT)
Number of subjects: 186
Study 36483140 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantity of cannabis use
Number of subjects: 186
Study 32142529 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wound infiltration (CWI) with local anaesthetics
Number of subjects: 62
Study 32142529 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia (EDA)
Number of subjects: 62
Study 32142529 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wound infiltration (CWI)
Number of subjects: 62
Study 36316102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy
Number of subjects: 86
Study 36316102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (sequential taper)
Number of subjects: 86
Study 36316102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (concurrent taper)
Number of subjects: 86
Study 36316102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (low glucocorticoid dose)
Number of subjects: 86
Study 36316102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (high glucocorticoid dose)
Number of subjects: 86
Study 36316102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept monotherapy (long-term glucocorticoid use)
Number of subjects: 86
Study 33675971 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopy‐assisted latissimus dorsi tendon transfer (LDT)
Number of subjects: 42
Study 33675971 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopy‐assisted superior capsular reconstruction (SCR)
Number of subjects: 42
Study 32357889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash containing Teucrium polium
Number of subjects: 22
Study 32357889 — intervention group
Group type: COMPARATOR
Intervention: Mouthwash without Teucrium polium (control)
Number of subjects: 22
Study 36325750 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial behavior
Number of subjects: 538
Study 32154784 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecofisio mobile app
Number of subjects: 110
Study 32154784 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional learning)
Number of subjects: 110
Study 33484137 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored text messaging intervention (NUDGE)
Number of subjects: 40
Study 33484137 — intervention group
Group type: COMPARATOR
Intervention: Attention-control condition
Number of subjects: 40
Study 32147465 — intervention group
Group type: EXPERIMENTAL
Intervention: Jigsaw method of learning
Number of subjects: 0
Study 32147465 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture-based methods
Number of subjects: 0
Study 35491562 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of social support
Number of subjects: 122
Study 35491562 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of HF knowledge
Number of subjects: 122
Study 35491562 — intervention group
Group type: EXPERIMENTAL
Intervention: Better self-care
Number of subjects: 122
Study 35491562 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and HF knowledge
Number of subjects: 122
Study 33849174 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 257
Study 33849174 — intervention group
Group type: COMPARATOR
Intervention: Urban adolescents
Number of subjects: 257
Study 33849174 — intervention group
Group type: COMPARATOR
Intervention: Rural adolescents
Number of subjects: 257
Study 34074223 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Program for Coping with PMS Symptoms based on IMB model
Number of subjects: 95
Study 34074223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training program)
Number of subjects: 95
Study 32453223 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pressure-adjustable orthosis (PO)
Number of subjects: 24
Study 32453223 — intervention group
Group type: COMPARATOR
Intervention: Conventional orthosis (CO)
Number of subjects: 24
Study 36369609 — intervention group
Group type: EXPERIMENTAL
Intervention: Test preparation (T) 10 mg
Number of subjects: 60
Study 36369609 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation (R) 10 mg
Number of subjects: 60
Study 36369609 — intervention group
Group type: EXPERIMENTAL
Intervention: Both T and R preparations
Number of subjects: 60
Study 33504589 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCS-only recruitment (n=213)
Number of subjects: 1012
Study 33504589 — intervention group
Group type: COMPARATOR
Intervention: In-person recruitment (n=87 eligible recruited)
Number of subjects: 1012
Study 33504589 — intervention group
Group type: EXPERIMENTAL
Intervention: Consenting patients (n=61)
Number of subjects: 1012
Study 32819944 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Healthy Heart (CHH) diet
Number of subjects: 360
Study 32819944 — intervention group
Group type: COMPARATOR
Intervention: Chinese usual diet
Number of subjects: 360
Study 33296841 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid replacement mimicking normal ultradian and circadian profile
Number of subjects: 15
Study 33296841 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid replacement retaining normal circadian but abolishing ultradian rhythm
Number of subjects: 15
Study 33296841 — intervention group
Group type: EXPERIMENTAL
Intervention: Current best oral replacement regime (suboptimal circadian and ultradian rhythm)
Number of subjects: 15
Study 33296841 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid replacement (various regimes)
Number of subjects: 15
Study 32869125 — intervention group
Group type: EXPERIMENTAL
Intervention: Ravulizumab (every-eight-weeks for 26 weeks)
Number of subjects: 33
Study 32869125 — intervention group
Group type: COMPARATOR
Intervention: Eculizumab (every-two-weeks for 26 weeks)
Number of subjects: 33
Study 34794198 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged course of TXA (Group B)
Number of subjects: 162
Study 34794198 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged course of DXM (Group C)
Number of subjects: 162
Study 34794198 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of TXA and DXM (Group D)
Number of subjects: 162
Study 34794198 — intervention group
Group type: COMPARATOR
Intervention: Control (Group A)
Number of subjects: 162
Study 33646727 — intervention group
Group type: EXPERIMENTAL
Intervention: Laughter therapy (twice a week for 6 weeks)
Number of subjects: 62
Study 33646727 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study 32638456 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide QRS-T angles
Number of subjects: 1094
Study 36415901 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intensive periodontal therapy
Number of subjects: 60
Study 36415901 — intervention group
Group type: COMPARATOR
Intervention: Delayed therapy (control group)
Number of subjects: 60
Study 32979521 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle dietary intervention
Number of subjects: 92
Study 32979521 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain-gastric interaction
Number of subjects: 92
Study 35397977 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal-based early progressive mobilisation program (passive abdominal massage, bed-side bicycle and ambulating)
Number of subjects: 83
Study 35397977 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal-based early progressive mobilisation program
Number of subjects: 83
Study 35397977 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 83
Study 32726473 — intervention group
Group type: EXPERIMENTAL
Intervention: epistemic volition intervention
Number of subjects: 412
Study 32726473 — intervention group
Group type: EXPERIMENTAL
Intervention: resolvable controversies intervention
Number of subjects: 412